Millipore (Billerica, Massachusetts) reported plans to open a new state-of-the-art applications and training facility in Singapore. The U.S.-based company is making the investment to meet the growing needs of its biotech customers who have operations in Asia.

Millipore’s Singapore facility will be located in Science Park, and is scheduled to open in early 2009. The facility will be designed to support biopharmaceutical manufacturing, continuing Millipore’s tradition of providing technical support in products and services. The company said the facility will allow local and regional customers to “investigate, explore and optimize their separations, purifications and monitoring processes” and be supported by local, regional and international experts.

Millipore is a provider of technologies, tools and services for bioscience research and biopharmaceutical manufacturing.

Iris Diagnostics ships urine analyzer

Iris Diagnostics (Chatsworth, California), a division of IRIS International, a leading provider of urinalysis systems and consumables for use in hospitals and commercial laboratories, said that it has shipped five iQ 200 ELITE automated urine microscopy analyzers to one of the largest clinical reference laboratories in Canada. The laboratory purchased the units from ESBE Scientific, Iris’ Canadian distributor.

The iQ 200 uses Auto-Particle Recognition, a well-trained neural network, to classify and quantitate twelve formed elements. The results can be auto-reported based on user-defined criteria and the images captured may be viewed on demand at the workstation monitor, “dramatically reducing” the need for manual microscopy and improving laboratory productivity, the company said.

“This sale ... represents our entry into the high-volume clinical reference laboratory segment in Canada,” said C sar Garc a, chairman/CEO of IRIS International. “[It] is a milestone in our international marketing campaign, which targets approximately 60 countries.”

New facility for Spacelabs in China

Spacelabs Healthcare (Issaquah, Washington), a division of OSI Systems (Hawthorne, California), reported the official opening of its new manufacturing facility in Suzhou, China.

The roughly 55,000-square-foot manufacturing facility, located about 50 miles east of Shanghai, initially will be focused on developing and manufacturing healthcare products for emerging markets. OSI said the facility also will serve as the cornerstone for the company’s emerging market activities, providing R&D, aftermarket service, training, marketing and sales support while also operating within its global supply chain.

Deepak Chopra, CEO of OSI, said, “This manufacturing facility complements our global manufacturing strategy and underscores our commitment to the emerging markets. By expanding our presence in the Asia Pacific region we are able to provide our range of products at competitive prices improving our competitiveness globally.

Spacelabs is a global provider of medical equipment and services, including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The company also provides centralized cardiac safety and diagnostic services to biopharmaceutical companies undertaking clinical trials.

The company has offices in the U.S., UK, Canada, France, Germany, Finland, India, China and Singapore.

Quintiles lab in India CAP-certified

Quintiles Transnational (Research Triangle Park, North Carolina) said that its central laboratory in Mumbai, India, has been certified by the College of American Pathologists (CAP). The lab began supporting clinical trials in 1Q07 and “has seen steady growth and has been adding services and analytical capabilities to a growing test menu,” Quintiles said.

“CAP certification validates our commitment to providing high-quality central laboratory services that fulfill rigorous regulatory requirements worldwide,” said Tom Wollman, senior VP, Quintiles Global Central Laboratories. “With the certification of the India laboratory, Quintiles Central Laboratory Services now has the largest wholly owned CAP-accredited laboratory network in the world.”
He added, “This tightly controlled network with CAP-certified laboratories in the U.S., Europe, South Africa, China, India and Singapore allows us to support global and regional trials in almost every country in the world.”

The Mumbai lab provides project management and logistical support, study specific laboratory kits for sites, local investigator support and samples management, storage and processing using consistent global methods.

ABMC, Devor Globa in Panama pact

American Bio Medica (ABMC; Kinderhook, New York) reported a distribution agreement with Devor Global in the Republic of Panama.

Devor has been granted the exclusive right to distribute ABMC’s Rapid STAT oral fluid drug test and its Rapid TOX Cup urine-based drug test in Latin America, subject to achieving and maintaining annual volume requirements. Devor also has been granted the non-exclusive right to distribute the rest of ABMC’s product lines within the territories of Latin America.

ABMC is a biotechnology company that makes accurate, cost-effective immunoassay diagnostic test kits.